Prøve GULL - Gratis
Pre-IPO placements surge as investors succumb to FOMO
Mint Mumbai
|November 13, 2025
Big investors are swooping in on companies right before their initial public offerings (IPOs) open, locking in shares that would be harder to get once subscriptions start.
The scramble for shares starts immediately after the IPO price band is announced, but before the IPO opens to anchor investors.
The recent IPOs of Lenskart, Physics Wallah and Aequs have seen investors buying shares in so-called pre-IPO placements, where investors snap up unlisted shares on the eve of an IPO. This is different from pre-IPO fundraises in which investors buy 12-18 months before the IPO, and anchor investments where large investors buy shares reserved for institutions in IPOs.
“In the current market, we are seeing a resurgence of late-stage interest in pre-IPO placements, particularly in high-growth and consumer-facing businesses,” said Prakash Bulusu, joint chief executive officer (CEO), IIFL Capital. “Investors want to lock in valuations that often look more attractive than post-listing levels.”
Denne historien er fra November 13, 2025-utgaven av Mint Mumbai.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Mumbai
Mint Mumbai
Lord’s Mark nears first $1 million MedTech shipment to the USA
On the Pathway to Achieve - $1 Million Milestone
1 mins
November 13, 2025
Mint Mumbai
Banks rush to unwind repledged gold loans
The Reserve Bank of India’s (RBI) recent gold loannorms have plugged a loophole that allowed banks and non-bank financiers to lend against gold repledged by informal lenders, according to four bankers with knowledge of the matter.
3 mins
November 13, 2025
Mint Mumbai
India's hiring intent rises to 11%: Report
After a year of muted single-digit growth, hiring intent has returned to double digits at 11%, up from 9.75% last year, supported by formalization and regional expansion, says a report.
1 min
November 13, 2025
Mint Mumbai
India and Botswana announce Cheetah translocation pact
India and Botswana on Wednesday formally declared the plan to translocate eight Cheetahs from the African nation during the state visit of President Droupadi Murmu.
1 min
November 13, 2025
Mint Mumbai
Fila reviews options for stake in Doms
Italian stationery company Fila SpA is reviewing options for its minority stake in India-listed Doms Industries Ltd as it seeks to deepen ties with the fast-growing Asian market, according to people familiar with the matter.
1 min
November 13, 2025
Mint Mumbai
INDIA TOPS MIGRATION BUT SHIFTS UNDERWAY
India has remained a leading source of immigrants to developed countries since it displaced China during the pandemic, according to a report by the Organization for Economic Co-operation and Development (OECD).
3 mins
November 13, 2025
Mint Mumbai
Retail inflation hits a record low in Oct
India’s retail inflation plunged to a record low of 0.25% in October from 1.44% the previous month, creating more room for a potential interest rate cut in December.
2 mins
November 13, 2025
Mint Mumbai
Pre-IPO placements surge as investors succumb to FOMO
Big investors are swooping in on companies right before their initial public offerings (IPOs) open, locking in shares that would be harder to get once subscriptions start.
2 mins
November 13, 2025
Mint Mumbai
What happens to your CGAS money if you don’t buy a house?
I sold a property in March 2024 and deposited ₹57 lakh of capital gains in a Capital Gain Account Scheme (CGAS) in May 2024. Since I will soon be moving abroad, I do not plan to buy a house using the deposited amount. How much tax will I have to pay now? I have been told that the tax rate is 12.5% instead of 20%. Is that correct? (If so, it would mean I pay a lower tax rate on a sale completed well before the new rule came into effect.)
1 mins
November 13, 2025
Mint Mumbai
Biocon banks on weight-loss, diabetes drugs to fuel near-term growth
Weight-loss and diabetes drugs such as semaglutide and liraglutide are expected to drive near-term growth in Biocon Ltd’s generics business, chief executive and managing director Siddharth Mittal told Mint on Wednesday.
2 mins
November 13, 2025
Listen
Translate
Change font size
